| Application no. and date | 13708435.6 (espacenet) (Federated) (European Patent Register), 20130311 | | Patent/reg. no. and date | DK/EP 2825558, 20190515 | | Publication date | 20150121 | | Priority no. and date | US 201261610128 P, 20120313, US 201261653598 P, 20120531, US 201261672987 P, 20120718 | | EP pub. no. and date |
EP 2825558 20150121 | | Effective date | | | Applicant/owner | F. Hoffmann-La Roche AG, Grenzacherstrasse 124
4070 Base, CH | | Applicant ref. no. | P68995DK01 | | Inventor | BERNASCONI, Corrado, Nansenstrasse 7
CH-8050 Zürich, CH,
BOLLAG, David, Amerbachstrasse 33
CH-4057 Basel, CH | | Representative | Plougmann Vingtoft A/S, Strandvejen 70, 2900 Hellerup, DK | | Opponent | | | IPC Class | A61K 31/337 (2006.01) , C07K 16/22 (2006.01) | | Title | Kombinationsterapi til behandling af ovariecancer | | Int. application no. | EP2013054818 | | Int. publication no. | WO2013135602 | | Related patent (certificate) | | | Status | DK/EP patent | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
